NO20083233L - Fremgangsmater og reagenser for genotyping ac HCV - Google Patents

Fremgangsmater og reagenser for genotyping ac HCV

Info

Publication number
NO20083233L
NO20083233L NO20083233A NO20083233A NO20083233L NO 20083233 L NO20083233 L NO 20083233L NO 20083233 A NO20083233 A NO 20083233A NO 20083233 A NO20083233 A NO 20083233A NO 20083233 L NO20083233 L NO 20083233L
Authority
NO
Norway
Prior art keywords
hcv
methods
species
reagents
genotyping
Prior art date
Application number
NO20083233A
Other languages
English (en)
Inventor
James Hnatyszyn
Marcellinus Gualbertus Hubertus Maria Beld
Toumy Guettouche
Remko Gouw
Carola Beatrijs Maria Van Der Meer
Original Assignee
Siemens Healthcare Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens Healthcare Diagnostics Inc filed Critical Siemens Healthcare Diagnostics Inc
Publication of NO20083233L publication Critical patent/NO20083233L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Foreliggende oppfinnelse er rettet mot fremgangsmåter og reagenser for å bestemme genotypen til en hepatitt C virus (HCV)-art som foreligger i en testprøve. Oppfinnelsen vedrører mer spesielt blandinger av degenererte amplifiseringsprimere og sekvenseringsprimere, og fremgangsmåter for anvendelse av slike primere, som er komplementære med et flertall av HCV-arter, og som er i stand til å generere nukleotidsekvensinformasjon for en region av NS5b fra HCV som for hver art er indikativ på typen og/eller undertypen til arten som foreligger i prøven.
NO20083233A 2005-12-23 2008-07-21 Fremgangsmater og reagenser for genotyping ac HCV NO20083233L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75376105P 2005-12-23 2005-12-23
PCT/US2006/062582 WO2007076493A2 (en) 2005-12-23 2006-12-22 Methods and reagents for genotyping hcv

Publications (1)

Publication Number Publication Date
NO20083233L true NO20083233L (no) 2008-07-21

Family

ID=38218857

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083233A NO20083233L (no) 2005-12-23 2008-07-21 Fremgangsmater og reagenser for genotyping ac HCV

Country Status (11)

Country Link
US (2) US20070259339A1 (no)
EP (1) EP1963493B1 (no)
JP (1) JP2009521235A (no)
KR (1) KR20080082662A (no)
CN (1) CN101341247A (no)
AU (1) AU2006330464A1 (no)
BR (1) BRPI0620445A2 (no)
CA (1) CA2638903A1 (no)
MX (1) MX2008008237A (no)
NO (1) NO20083233L (no)
WO (1) WO2007076493A2 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090325145A1 (en) * 2006-10-20 2009-12-31 Erwin Sablon Methodology for analysis of sequence variations within the hcv ns5b genomic region
EP2236624B1 (en) 2007-08-09 2012-11-07 Federalnoe Gosudarstvennoe Byudzhetnoe Uchrezhdenie Nauki Institut Molekulyarnoi Biologi Im. V.A. Engelgardta Rossiiskoi Akademii Nauk Method for identifying the genotype and subtype of hepatitis c virus on a biological microchip
CN103154270B (zh) * 2010-10-04 2018-01-09 霍夫曼-拉罗奇有限公司 用于rt‑pcr反应缓冲液中的细胞裂解的方法
JP5911495B2 (ja) * 2010-10-04 2016-04-27 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 同じ反応容器内での細胞溶解およびｐｃｒのための方法
JP6174999B2 (ja) * 2010-10-04 2017-08-02 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ Ｐｃｒ反応緩衝液中での細胞溶解のための方法
CN102286644B (zh) * 2011-08-26 2013-04-10 李艳 一种对丙型肝炎病毒进行基因分型的试剂盒
FR2989089B1 (fr) 2012-04-04 2020-02-07 Etablissement Francais Du Sang Oligonucleotides modifies comprenant des fonctions thiol et leur utilisation pour la detection d'acides nucleiques
CN102719558A (zh) * 2012-05-30 2012-10-10 杭州艾迪康医学检验中心有限公司 用于检测丙肝病毒基因型的试剂盒
GB2520021A (en) * 2013-11-06 2015-05-13 Vela Operations Pte Ltd HCV genotyping algorithm
US20150176060A1 (en) * 2013-12-20 2015-06-25 Roche Molecular Systems, Inc. Method For Coding Of Multiple PCR Reactions For Assay Recognition
US10987133B2 (en) 2016-05-02 2021-04-27 Entellus Medical, Inc. Nasal valve implants and methods of implanting the same
US11961590B2 (en) 2017-04-17 2024-04-16 Seegene, Inc. Methods for preparing optimal combination of oligonucleotides
KR102335277B1 (ko) 2017-08-11 2021-12-07 주식회사 씨젠 복수의 타겟 핵산서열을 최대의 타겟 커버리지로 검출하기 위한 올리고뉴클레오타이드의 제작방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US5352600A (en) 1986-08-22 1994-10-04 Hoffmann-La Roche Inc. Purified thermostable enzyme
US5079352A (en) 1986-08-22 1992-01-07 Cetus Corporation Purified thermostable enzyme
US4889818A (en) 1986-08-22 1989-12-26 Cetus Corporation Purified thermostable enzyme
US5427911A (en) 1990-05-01 1995-06-27 Yale University Coupled amplification and sequencing of DNA
ATE143057T1 (de) 1994-10-17 1996-10-15 Harvard College Dns polymerase mit veränderter nukleotid- bindungstelle
US6007983A (en) 1995-12-22 1999-12-28 Visible Genetics Inc. Method and kit for evaluation of HIV mutations
US7196183B2 (en) * 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent

Also Published As

Publication number Publication date
US20100196876A1 (en) 2010-08-05
US20070259339A1 (en) 2007-11-08
EP1963493A4 (en) 2009-11-25
AU2006330464A1 (en) 2007-07-05
US8735063B2 (en) 2014-05-27
JP2009521235A (ja) 2009-06-04
EP1963493A2 (en) 2008-09-03
KR20080082662A (ko) 2008-09-11
WO2007076493A2 (en) 2007-07-05
CA2638903A1 (en) 2007-07-05
BRPI0620445A2 (pt) 2011-11-08
EP1963493B1 (en) 2017-02-22
WO2007076493A3 (en) 2008-04-24
WO2007076493A8 (en) 2017-02-02
MX2008008237A (es) 2008-11-06
CN101341247A (zh) 2009-01-07

Similar Documents

Publication Publication Date Title
NO20083233L (no) Fremgangsmater og reagenser for genotyping ac HCV
Ansari et al. Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus
Powdrill et al. Contribution of a mutational bias in hepatitis C virus replication to the genetic barrier in the development of drug resistance
Li et al. Elucidation of hepatitis C virus transmission and early diversification by single genome sequencing
Farci New insights into the HCV quasispecies and compartmentalization
Galli et al. Comparative analysis of the molecular mechanisms of recombination in hepatitis C virus
Fishman et al. The quasispecies nature and biological implications of the hepatitis C virus
WO2005067643A3 (en) Determination of hepatitis c virus genotype
US20230167513A1 (en) Methos for rapid detection and identification of viral nucleic acids
Wylie et al. Genome sequence of enterovirus D68 from St. Louis, Missouri, USA
Rauch et al. Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen–restricted immune pressure
Guglietta et al. Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection
Noppornpanth et al. Characterization of hepatitis C virus deletion mutants circulating in chronically infected patients
Fahnøe et al. Full-length open reading frame amplification of hepatitis C virus
Wei et al. Development and validation of a template-independent next-generation sequencing assay for detecting low-level resistance-associated variants of hepatitis C virus
WO2017021471A1 (en) Methods for amplifying and sequencing the genome of a hepatitis c virus
Ramachandran et al. Evaluation of intra-host variants of the entire hepatitis B virus genome
Davis et al. Hepatitis E virus: whole genome sequencing as a new tool for understanding HEV epidemiology and phenotypes
Cuypers et al. A near-full length genotypic assay for HCV1b
Rossi et al. Multiregion deep sequencing of hepatitis C virus: An improved approach for genetic relatedness studies
Casanova et al. A complete molecular biology assay for hepatitis C virus detection, quantification and genotyping
Trémeaux et al. Amplification and pyrosequencing of near-full-length hepatitis C virus for typing and monitoring antiviral resistant strains
Irving et al. Development of a high-throughput pyrosequencing assay for monitoring temporal evolution and resistance associated variant emergence in the Hepatitis C virus protease coding-region
Gededzha et al. Prediction of T-cell epitopes of hepatitis C virus genotype 5a
CN108018376B (zh) 一种用于丙肝病毒分型和耐药位点检测的探针和方法

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application